Stockscreener 앱 받기
3.95
1.28%
0.05
시간 외 거래:
3.94
-0.01
-0.25%
전일 마감가:
$3.90
열려 있는:
$3.92
하루 거래량:
2.35M
Relative Volume:
0.51
시가총액:
$1.40B
수익:
$9.68M
순이익/손실:
$-250.64M
주가수익비율:
-2.8218
EPS:
-1.3998
순현금흐름:
$-89.83M
1주 성능:
-7.49%
1개월 성능:
+12.54%
6개월 성능:
+13.18%
1년 성능:
+188.32%
1일 변동 폭
$3.80
$3.96
1주일 범위
$3.80
$4.37
52주 변동 폭
$1.225
$5.465
Precigen Inc Stock (PGEN) Company Profile
명칭
Precigen Inc
전화
301-556-9900
주소
20374 SENECA MEADOWS PARKWAY, GERMANTOWN, MD
Compare PGEN vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGEN
Precigen Inc
|
3.95 | 1.38B | 9.68M | -250.64M | -89.83M | -1.3998 |
VRTX
Vertex Pharmaceuticals Inc
|
435.65 | 112.35B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
746.00 | 79.71B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
828.35 | 52.29B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
320.13 | 44.48B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
320.70 | 35.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Precigen Inc Stock (PGEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-15 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2024-03-22 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-05-23 | 개시 | JP Morgan | Neutral |
| 2022-11-18 | 개시 | Cantor Fitzgerald | Overweight |
| 2021-02-25 | 개시 | Stifel | Buy |
| 2021-02-22 | 개시 | Wells Fargo | Overweight |
| 2021-02-18 | 개시 | B. Riley Securities | Buy |
| 2020-05-08 | 개시 | H.C. Wainwright | Buy |
모두보기
Precigen Inc 주식(PGEN)의 최신 뉴스
Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative? - simplywall.st
Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage - MSN
These analysts boost their forecasts on Precigen following Q4 results - MSN
Precigen Reports 'Robust Uptake' of New Drug for Rare Respiratory Disease; First Quarter Revenue Expected to Top $18 Million - ACCESS Newswire
Precigen gains after 2025 results on Papzimeos' outlook - MSN
Precigen (NASDAQ:PGEN) Trading Down 5.6%Here's Why - MarketBeat
Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? - Insider Monkey
Aug Closing: Whats the fair value of Precigen Inc stockMarket Performance Recap & Expert Curated Trade Ideas - baoquankhu1.vn
Take Profit: Is Precigen Inc a turnaround storyWeekly Gains Summary & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Precigen, Inc. (PGEN) poised for growth on respiratory papillomatosis treatment prospects - MSN
Wall Street Bullish on Precigen (PGEN) As the Company Transitions to Commercial Stage - Insider Monkey
Take Profit: What are Precigen Incs recent SEC filings showingGap Down & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Precigen (PGEN) price target increased by 11.76% to 9.69 - MSN
CapEx per share of Precigen Inc – SWB:I5X - TradingView — Track All Markets
PGEN Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Precigen sees Q1 revenue exceeding $18M, consensus $20.8M - Yahoo Finance
Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 By Investing.com - Investing.com Australia
Precigen Reports Strong Demand for New Rare Disease Drug - National Today
Precigen (PGEN) Eyes Revenue Growth with PAPZIMEOS Success - GuruFocus
Precigen (PGEN) Sees Strong Demand for Papzimeos Immunotherapy - GuruFocus
(PGEN) Precigen Expects Q1 Revenue to Exceed $18M, vs. FactSet Est of $20.8M - marketscreener.com
Precigen reports $3.4M in PAPZIMEOS sales for Q4 2025 - Investing.com
Precigen Reports 'Robust Uptake' of New Drug for Rare Respirator - GuruFocus
Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects - Yahoo Finance
Precigen (PGEN) Is Up 7.4% After Surging Revenue And Wider 2025 Losses Are Reported – Has The Bull Case Changed? - simplywall.st
Precigen Stock Hits Day Low of $3.94 Amid Price Pressure - Markets Mojo
PGEN Should I Buy - Intellectia AI
Precigen to Participate in H.C. Wainwright Virtual Fireside Chat - Intellectia AI
Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 4,772,781 Shares of Stock - MarketBeat
PGEN SEC FilingsPrecigen Inc 10-K, 10-Q, 8-K Forms - Stock Titan
PGEN.O Technical Analysis & Stock Price Forecast - Intellectia AI
PGEN PE Ratio & Valuation, Is PGEN Overvalued - Intellectia AI
Precigen, Inc. (NASDAQ:PGEN) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat
Precigen, Inc. (NASDAQ:PGEN) Q4 2025 earnings call transcript - MSN
PGEN.O Stock News Today | Earnings, Events & Price Alerts - intellectia.ai
4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk - Stock Titan
Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake - Stock Titan
Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat - MarketBeat
Precigen (NASDAQ:PGEN) Stock Price Up 11.2%What's Next? - MarketBeat
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 - StreetInsider
[144] PRECIGEN, INC. SEC Filing - Stock Titan
Precigen Inc (PGEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.45%
0.77%
자본화:
|
볼륨(24시간):